Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-24T13:29:23.721Z Has data issue: false hasContentIssue false
  • English
  • Français

La reducción del consumo de alcohol con una nueva intervención farmacológica

Published online by Cambridge University Press:  12 May 2020

W. Sperling  and
O. M. Lesch
W. Sperling
Affiliation:
Departamento de Psiquiatría, Universidad Friedrich Alexander de Erlangen, Erlangen, Alemania
O. M. Lesch
Affiliation:
Departamento de Psiquiatría, Universidad de Viena, Viena, Austria
Get access

Resumen

El desarrollo de agentes farmacológicos en el tratamiento del alcoholismo representa una de las muchas maneras diferentes de suprimir la ingesta de alcohol. Se han examinado sustancias específicas con respecto a la hipotética participación de sistemas neuroquímicos diferentes en el «ansia de alcohol” en modelos animales (especialmente ratas) y cada vez más en el ser humano. Se han descrito resultados prometedores en la reducción del «ansia de alcohol » con el uso de diferentes clases de sustancias químicas. Por tanto, difícilmente se puede explicar el «ansia» sobre la base de un déficit en un solo sistema (neurotransmisor) neuroquímico. Los datos apoyan esta conclusión. La eficacia de muchas sustancias contra el ansia, descrita en estudios más pequeños, se debe confirmar primero en trabajos clínicos en una escala más amplia.

Keywords

ansiaalcoholismoserotoninaopioideslitioacamprosate
Type
Revisión
Information
European Psychiatry (Ed. Española) , Volume 4 , Issue 2 , March 1997 , pp. 77 - 87
Copyright
Copyright © European Psychiatric Association 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografia

Ades, JBarrias, JABesson, JBorg, SLesch, OMGuidelines on evaluation of treatment of acohol dependence. J Alcohol Related Addict 1994; xxx (Supl).Google Scholar
Amit, ZSmith, BRNeurotransmitter Systems in ethanol intake. Satellite Symposium to the 5th ISBRA conference - Novel pharmacological interventions for alcoholism - Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Bilsky, EJDelconte, JMianserin, a serotonergic antagonist, and intake of an alcoholism beverage. Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Borg, VBromocriptine in the prevention of alcohol abuse. Acta Psychiatr Scand 1983; 68 (2): 100–10.CrossRefGoogle ScholarPubMed
Cloninger, CRSigvardsson, SGilligan, SBGenetic heterogenity and the classification of alcohol. Adv Alcohol Subst Abuse 1988; 7: 3–16.Google Scholar
Compagnon, RSerotonin in animal models of alcoholism. Alcohol and Alcoholism 1993; 2: 215–9.Google ScholarPubMed
Diagnostische Kriterien and Differentialdiagnosen des Diagnostischen und statistichen Manuals psychischer Störungen DSM-III-R. Weinheim, Basel: Beltz, 1989.Google Scholar
De Vry, J5-HT-1A receptors in anxiety. In: Brilley, M et al, eds. New Concepts in Anxiety. London: Mac Millon, 1991: 94–129.CrossRefGoogle Scholar
Dillon, KAAutographic analysis of serotonin 5-HT-1A receptor binding in the human brain postmortem: Effects o f age and alcohol. Brain Res 1991; 554: 56–64.CrossRefGoogle Scholar
Dorus, WOstrow, DGAnton, RCushman, PCollins, JFSchaefer, MLithium treatment of depressed and non-depressed alcoholics (comments). JAMA 1989; 262: 1680–1.CrossRefGoogle Scholar
Engel, JAFahlke, CHard, ESvensson, LSerotonergic involvement in ethanol intake. Satellite Symposium to the 5th ISBRA conference - Novel pharmacological interventions for alcoholism -Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Fawcett, JClark, DCEvaluation of lithium therapy for alcoholism. J Clim Psychiatry 1984; 45: 494–9.Google ScholarPubMed
Fawcett, MDClark, DCA double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism. Arch Gen Psychiatry 1987; 44: 248–56.CrossRefGoogle ScholarPubMed
Fröhlich, JCZweifel, MKurtz, DOpioid antagonists selectively suppress ethanol intake. Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Gallimberti, LFerri, MFerrara, SDFadda, FGessa, GIGamma-hydroxybutyric acid in the treatment of alcohol dependence: A double-blind study. Alcohol Clin Exper Res 1992; 16 (4): 673–6.CrossRefGoogle ScholarPubMed
Gorrelick, DAParedes, AEffects of fluoxetine and alcohol consumption in male alcoholics. Alcoholism Clin Exper Res 1992; 16: 261–5.CrossRefGoogle Scholar
Gottlieb, LDHorwitz, RIKraus, MLRandomized controlled trial in alcohol relapse prevention, role of atenolol, alcohool craving and treatment adrherence. J Subst Abuse Treat 1994; 11: 253–8.CrossRefGoogle Scholar
Grupp, LAAngiotensin converting enzyme inhibitors reduce alcohol consumption in rats: Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Higgins, GASellers, EMStrategies for the identification of novel serotonergic treatments to selectively reduce ethanol consumption. Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Ho, ADTsai, CSEffects of lithium on alcohol preference and withdrawal. Ann NY Acad Sci 1976; 273: 371–7.CrossRefGoogle ScholarPubMed
Hubbel, CLChrisbacher, GABilsky, EJReid, LDAngiotensin converting enzyme inhibitors and intake of an alcoholic beverage. Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Judd, LLHuey, LYLithium antagonizes ethanol intoxication in alcoholics. Am J Psychiatry 1984; 141: 1517–21.Google ScholarPubMed
Kranzler, HFluvoxamine is poorly tolerated by alcoholics. Plenary lecture and panel discussion in: Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Kranzler, HRBurleson, JADe Boca, FKBuspirone treatment of anxious alcoholics. A placebo-controlled trial. Arch Gen Psychiatry 1994; 51: 720–31.Google ScholarPubMed
Kornet, MBehavioural and neuropharmacological aspects of experimental alcohol addiction in rhesus monkeys. Rijswijk TNO 1991.Google Scholar
Lejoyeux, MAdes, JEvaluation of lithium treatment in alcoholism. Alcohol Alcoholism 1993; 28: 273–9.Google ScholarPubMed
Lesch, OMWalter, HBonte, WGrünberger, JMusalek, MSprung, REtiology of subgroups in chronic alcoholism and different mechanisms in transmitter Systems. In: Norman Palmer, T ed. Alcoholism: a Molecular Perspective. Nato Asi Series A: Life Sciences Vol. 206. New York: Plenum Press, 1993: 145-60.Google Scholar
Lesch, OMPoldrugo, FThe diagnosis of alcoholism: New perspectives in classification. Alcologia 1994; 6: 11–5.Google Scholar
Linnoila, MGeorge, DTWozniak, KSerotonin and alcohol. Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Littrell, JUnderstanding and Treating Alcoholism, Vol. 2: Biological, Psychological and Social Aspects o f Alcohol Consumption and Abuse. New Jersey, 1991.Google Scholar
Malcom, RA placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res 1992; 16: 1007–13.CrossRefGoogle Scholar
Malley, SOJaffe, AChang, GWitte, GNaltrexone treatment of alcohol dependence. Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
McBride, WJ.Serotonin in animal models of alcoholism. Alcohol Alcoholism 1990; 2: 215–9.Google Scholar
Merry, JReynolds, CMProphylactic treatment of alcoholism by lithium carbonate. Lancet 1976; 2: 481–2.Google Scholar
Meyer, RPreclinical and clinical methods for testing drugs to decrease alcohol consumption. Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Modell, JGMoutz, JMGlaser, FBLee, JYEffect of haloperidol on measures of craving and impaired control in alcoholic subjects. Alcohol Clinical Exp Res 1993; 17 (2): 234–40.CrossRefGoogle ScholarPubMed
Naranjo, CAKadlec, KEEllers, EMEvaluation of the effects of serotonin uptake inhibitors in alcoholics: a review. Statellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Naranjo, CASellers, EMKadlec, KSanhueza, PGrupp, LEnalapril does not decrease alcohol intake in normotensive alcoholics. Satellite to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Naranjo, CABrenner, KEEffects of citalopram and a brief psychosocial intervention on alcohol intake, dependence and problems. Addiction 1995; 90: 87–94.CrossRefGoogle Scholar
Nichols, MLBilsky, EDHubbel, CLPeripheral administration of TIQ's and intake of an alcohol beverage. Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Nichols, MLHubbel, CLReid, LDStereoselectivity of opioids effects on intake of an alcoholic beverage. Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Olbrich, RWatzl, HVolter, MSiedow, HLithium in ther Behandlung chronischer Alkoholkranker mit zerebralen Schädigungen - eine kontrollierte Studie. Nervenartz 1991; 62: 182–6.Google Scholar
Opitz, KThe effect of clonidine and related substances on voluntary ethanol consumption in rats. Drug Alcohol Depend 1990; 25: 43–8.CrossRefGoogle ScholarPubMed
Pelc, ILebon, OVerbank, PLehert, PHOpsomer, LCalcium-acetylhomotaurinate for maintaining abstinence in weaned alcoholic patients. Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Reid, LRWong, D5-Hydroxytryptamine-lA receptor in brain areas o f alcohol preferring and non-preferring rats. Fased J 1991; 5: 865.Google Scholar
Rommelspacher, HSchmidt, LGMay, TPlasma norharman, carboline levels elevated in chronic alcoholics. Clin Exp Res 1991; 15: 553.CrossRefGoogle ScholarPubMed
Sano, HCircadian variations in plasma 5-HTAA level during and after withdrawal. Acta Psychiat Scand 1993; 87: 291–6.CrossRefGoogle Scholar
Sinclair, JDPreclinical and clinical methods for testing drugs to decrease alcohol consumption. Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar
Schreiber, RDe Vry, JIpsapirone and 8-OH-DPAT reduce ethanol preference in rats: involvement of presynaptic 5-HT-1A receptors. Psychopharmacology 1993; 112: 100- 10.CrossRefGoogle Scholar
Swift, RMWhelihan, WKutznesov, ONaltrexone induced alterations in human ethanol intoxication. Am J Psychiatry 1994; 151: 1463–7.Google ScholarPubMed
Tollefson, GDSerotonin and alcoholism: Interrelationships. Psychopathology 1989; 22: 37–48.CrossRefGoogle ScholarPubMed
Volpicelli, JRAltermann, AIHayashida, MO’Brien, CPNaltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992; 49 (11): 876–80.CrossRefGoogle ScholarPubMed
Volpicelli, JRWatson, NTKing, ACEffect of naltrexone on alcohol #«high” in alcoholics. Am J Psychiatry 1995: 152: 613–5.Google ScholarPubMed
Wong, DTSerotonergic and adrenergic receptors in alcohol preferring and non-preferring rats. J Neural Trans 1988; 71: 207–18.CrossRefGoogle ScholarPubMed
Zeise, MLKasparow, MCapogna, MZieglgansberger, WCalciumdiacetylhomotaurinate decreases the action of excitatory amino acids in the rat neocortex in vitro. Satellite Symposium to the 5th ISBRA Conference - Novel pharmacological interventions for alcoholism. Addiction Research Foundation, Toronto, Canada, 1990.Google Scholar